More on CEMI
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| REVENUES: | |
| Net product sales | 2.5M |
| License and royalty revenue | 77.75K |
| R&D, milestone and grant revenue | 1.17M |
| TOTAL REVENUES | 3.75M |
| Cost of product sales | 1.79M |
| GROSS MARGIN | 1.95M |
| OPERATING EXPENSES: | |
| Research and development expenses | 2.26M |
| Selling, general and administrative expenses | 1.83M |
| Total operating Expenses | 4.1M |
| NET INCOME FROM OPERATIONS | -2.14M |
| OTHER INCOME (EXPENSES): | |
| Interest income | 5.86K |
| Interest expense | 0 |
| TOTAL OTHER INCOME (EXPENSES) | |
| NET INCOME BEFORE INCOME TAXES | -2.14M |
| Provision for income taxes | 0 |
| NET INCOME | -2.14M |
| Basic net income per share | -0.19 |
| Diluted net income per share | -0.19 |
| Weighted average number of shares outstanding, basic | 11.14M |
| Weighted average number of shares outstanding, diluted | 11.14M |
Entities mentioned with CEMI
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- S3 | View Related Stories »
- 13G | View Related Stories »
- 14D9 | View Related Stories »
- Pre Market Movers | View Related Stories »
- The Benchmark Company | View Related Stories »
- Show More...
